The site includes a 52-acre campus, with 28 acres available for future expansion. The 74,577 sq. ft., (6,927 sq. m.) facility includes a downstream processing building, capable of handling complex purification steps, analytical laboratories for raw materials, environmental monitoring and release testing and a mechanical workshop for equipment maintenance and calibration.
The intention to sell the site comes more than six months after the company closed a Puerto Rico manufacturing site and said its focus would move to its insulin and biologics pipeline.